There are still many controversies in defining and evaluating mastocytosis.
One of the aspects that is missing is a system for clinical evaluation of
mastocytosis of the skin. A calculation based on a semi-quantitative analys
is of three aspects of mastocytosis was designed. The method is called the
scoring index of mastocytosis (SCORMA). The clinical use of SCORMA is advoc
ated.